Smart Assays is a unique service company, established in 2005 by Dr. Raphael Mayer.
We specializes in tailor made R&D services with emphasis of research. We focus on validation of early stage projects and mechanism of action studies using methodologies such as assay development, drug discovery, research histopathology, bioanalytic research and much more.
With more than 80% of our employees being PhDs and post-docs we successfully deal with elaborate issues such as development of assays for compounds screening, characterization of protein-protein interaction, binding and enzymatic activity assays, inflammation and immunohistochemical profiling and many more. Our team helps companies to further develop early stage therapeutics projects and support companies at advance clinical stages in areas such as release tests, mechanism of action studies, and biochemical and histological R&D.